标准治疗-话题@MedSci - 梅斯（MedSci）

#标准治疗#

60篇内容 | 2344人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1948269, encodeId=f963194826915, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=喜大普奔 | III期FLAURA 研究OS取得阳性结果，EGFR突变晚期非小细胞肺癌一线标准治疗已成定论, objectType=article, longId=177574, objectId=06bb1e7574a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06bb1e7574a5, replyNumber=0, likeNumber=77, createdTime=2020-02-15, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06bb1e7574a5, moduleTitle=喜大普奔 | III期FLAURA 研究OS取得阳性结果，EGFR突变晚期非小细胞肺癌一线标准治疗已成定论, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=06bb1e7574a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948264, encodeId=264a19482642d, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Arthritis Rheumatol：贝利木单抗联合标准治疗对系统性红斑狼疮的安全性和疗效长达13年, objectType=article, longId=160523, objectId=40ee16052378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ee16052378, replyNumber=0, likeNumber=61, createdTime=2019-08-02, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ee16052378, moduleTitle=Arthritis Rheumatol：贝利木单抗联合标准治疗对系统性红斑狼疮的安全性和疗效长达13年, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=40ee16052378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948267, encodeId=a3f8194826e7e, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=周爱萍教授深入解读KEYNOTE-240研究：进一步证实帕博利珠单抗HCC二线标准治疗地位, objectType=article, longId=174829, objectId=8b6f1e482903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b6f1e482903, replyNumber=0, likeNumber=67, createdTime=2020-06-08, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b6f1e482903, moduleTitle=周爱萍教授深入解读KEYNOTE-240研究：进一步证实帕博利珠单抗HCC二线标准治疗地位, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8b6f1e482903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948262, encodeId=7c231948262e7, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Ann Rheum Dis：贝利木单抗与标准治疗的器官损害比较, objectType=article, longId=157362, objectId=c61215e362b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61215e362b3, replyNumber=0, likeNumber=63, createdTime=2019-06-22, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61215e362b3, moduleTitle=Ann Rheum Dis：贝利木单抗与标准治疗的器官损害比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c61215e362b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948261, encodeId=825119482613d, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, objectType=article, longId=141676, objectId=ab751416e6bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab751416e6bd, replyNumber=0, likeNumber=81, createdTime=2019-06-11, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab751416e6bd, moduleTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ab751416e6bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948256, encodeId=565c194825604, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=36种高价药物进国家医保肿瘤患者将受惠可坚持标准治疗, objectType=article, longId=114704, objectId=637a114e0450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=637a114e0450, replyNumber=0, likeNumber=60, createdTime=2018-06-04, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=637a114e0450, moduleTitle=36种高价药物进国家医保肿瘤患者将受惠可坚持标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=637a114e0450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948257, encodeId=7ecc194825ee3, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位, objectType=article, longId=121278, objectId=c84a1212e86d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84a1212e86d, replyNumber=0, likeNumber=77, createdTime=2018-08-24, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84a1212e86d, moduleTitle=【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c84a1212e86d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948259, encodeId=3323194825937, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=JAMA：电场疗法联合替莫唑胺维持化疗用于标准治疗后胶质母细胞瘤患者, objectType=article, longId=124048, objectId=08b1124048df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08b1124048df, replyNumber=0, likeNumber=0, createdTime=2018-02-25, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08b1124048df, moduleTitle=JAMA：电场疗法联合替莫唑胺维持化疗用于标准治疗后胶质母细胞瘤患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=08b1124048df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948258, encodeId=534719482580d, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Lancet：多学科讨论：急性冠脉综合征患者PCI后降阶梯治疗不输标准治疗, objectType=article, longId=121674, objectId=f9961216e4a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9961216e4a5, replyNumber=0, likeNumber=73, createdTime=2018-04-29, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9961216e4a5, moduleTitle=Lancet：多学科讨论：急性冠脉综合征患者PCI后降阶梯治疗不输标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f9961216e4a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948260, encodeId=8ddd19482605a, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=J Clin Oncol：卡博替尼——肾癌伴骨转移患者新的标准治疗, objectType=article, longId=126187, objectId=bbe412618e3e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbe412618e3e, replyNumber=0, likeNumber=75, createdTime=2018-09-20, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbe412618e3e, moduleTitle=J Clin Oncol：卡博替尼——肾癌伴骨转移患者新的标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bbe412618e3e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948255, encodeId=b928194825545, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Lancet Oncol:表阿霉素/顺铂/卡培他滨新辅助治疗食管腺癌并不优于标准治疗, objectType=article, longId=108311, objectId=a8c210831193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8c210831193, replyNumber=0, likeNumber=73, createdTime=2017-09-05, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8c210831193, moduleTitle=Lancet Oncol:表阿霉素/顺铂/卡培他滨新辅助治疗食管腺癌并不优于标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a8c210831193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948254, encodeId=62eb19482546e, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Hepatology：HIV合并HCV，标准治疗效果如何?, objectType=article, longId=102298, objectId=68f6102298f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68f6102298f3, replyNumber=0, likeNumber=115, createdTime=2017-10-01, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68f6102298f3, moduleTitle=Hepatology：HIV合并HCV，标准治疗效果如何?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=68f6102298f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948252, encodeId=ec65194825220, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Cancer Treat Rev：一/二线标准治疗失败的转移性结直肠癌，下一步怎么办？, objectType=article, longId=99496, objectId=211e9949680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=211e9949680, replyNumber=0, likeNumber=65, createdTime=2017-07-18, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=211e9949680, moduleTitle=Cancer Treat Rev：一/二线标准治疗失败的转移性结直肠癌，下一步怎么办？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=211e9949680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948253, encodeId=ac80194825390, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=JCO：Her-2阳性胃或胃食管结合部腺癌：标准治疗vs高剂量的曲妥珠单抗联合化疗（IIIb期多中心随机研究）, objectType=article, longId=101489, objectId=321410148959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=321410148959, replyNumber=0, likeNumber=69, createdTime=2017-10-31, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=321410148959, moduleTitle=JCO：Her-2阳性胃或胃食管结合部腺癌：标准治疗vs高剂量的曲妥珠单抗联合化疗（IIIb期多中心随机研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=321410148959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948251, encodeId=f61a1948251a1, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=ASTRO 2016：研究者称，立体定向放射外科治疗应成为脑转移瘤的标准治疗, objectType=article, longId=78847, objectId=d78de884767, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d78de884767, replyNumber=0, likeNumber=68, createdTime=2016-12-02, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d78de884767, moduleTitle=ASTRO 2016：研究者称，立体定向放射外科治疗应成为脑转移瘤的标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d78de884767)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948250, encodeId=ee7519482501f, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=两篇Nature聚焦：肾癌新药战胜现有标准治疗, objectType=article, longId=76901, objectId=e02ee6901a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02ee6901a2, replyNumber=0, likeNumber=85, createdTime=2016-10-29, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02ee6901a2, moduleTitle=两篇Nature聚焦：肾癌新药战胜现有标准治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e02ee6901a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948246, encodeId=79361948246f1, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=JAMA：标准治疗联合右美托咪啶治疗可减少躁动型谵妄患者机械通气的时间(DahLIA研究), objectType=article, longId=66586, objectId=06446658661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06446658661, replyNumber=0, likeNumber=87, createdTime=2016-10-24, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06446658661, moduleTitle=JAMA：标准治疗联合右美托咪啶治疗可减少躁动型谵妄患者机械通气的时间(DahLIA研究), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=06446658661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948247, encodeId=dd4a194824e2e, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=JAMA：肺气肿的治疗：支气管内线圈治疗 vs 标准治疗（RENEW）, objectType=article, longId=68288, objectId=e8cd6828824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8cd6828824, replyNumber=0, likeNumber=72, createdTime=2017-03-09, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8cd6828824, moduleTitle=JAMA：肺气肿的治疗：支气管内线圈治疗 vs 标准治疗（RENEW）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e8cd6828824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948245, encodeId=bfd4194824549, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=Diabetes Care：糖尿病标准治疗时，低血糖可影响动脉粥样硬化进展, objectType=article, longId=63641, objectId=a9186364151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9186364151, replyNumber=0, likeNumber=74, createdTime=2016-08-18, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9186364151, moduleTitle=Diabetes Care：糖尿病标准治疗时，低血糖可影响动脉粥样硬化进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a9186364151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1948244, encodeId=b60f1948244ec, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, objectTitle=NEJM：低温联合标准治疗并不能更好的改善颅脑创伤患者的脑功能, objectType=article, longId=60769, objectId=349560e6970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=349560e6970, replyNumber=0, likeNumber=69, createdTime=2016-10-27, rootId=0, userName=小小小向日葵, userId=72bf2500198, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=349560e6970, moduleTitle=NEJM：低温联合标准治疗并不能更好的改善颅脑创伤患者的脑功能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=349560e6970)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

标准治疗

2020-05-29

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

喜大普奔 | III期FLAURA 研究OS取得阳性结果，EGFR突变晚期非小细胞肺癌一线标准治疗已成定论

2020-02-15

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

Arthritis Rheumatol：贝利木单抗联合标准治疗对系统性红斑狼疮的安全性和疗效长达13年

2019-08-02

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

周爱萍教授深入解读KEYNOTE-240研究：进一步证实帕博利珠单抗HCC二线标准治疗地位

2020-06-08

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

Ann Rheum Dis：贝利木单抗与标准治疗的器官损害比较

2019-06-22

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！

2019-06-11

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

36种高价药物进国家医保肿瘤患者将受惠可坚持标准治疗

2018-06-04

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位

2018-08-24

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

JAMA：电场疗法联合替莫唑胺维持化疗用于标准治疗后胶质母细胞瘤患者

2018-02-25

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Lancet：多学科讨论：急性冠脉综合征患者PCI后降阶梯治疗不输标准治疗

2018-04-29

一叶知秋 (审核中...)

前往app查看评论内容

#标准治疗#

J Clin Oncol：卡博替尼——肾癌伴骨转移患者新的标准治疗

2018-09-20

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Lancet Oncol:表阿霉素/顺铂/卡培他滨新辅助治疗食管腺癌并不优于标准治疗

2017-09-05

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Hepatology：HIV合并HCV，标准治疗效果如何?

2017-10-01

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Cancer Treat Rev：一/二线标准治疗失败的转移性结直肠癌，下一步怎么办？

2017-07-18

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

JCO：Her-2阳性胃或胃食管结合部腺癌：标准治疗vs高剂量的曲妥珠单抗联合化疗（IIIb期多中心随机研究）

2017-10-31

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

ASTRO 2016：研究者称，立体定向放射外科治疗应成为脑转移瘤的标准治疗

2016-12-02

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

两篇Nature聚焦：肾癌新药战胜现有标准治疗

2016-10-29

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

JAMA：标准治疗联合右美托咪啶治疗可减少躁动型谵妄患者机械通气的时间(DahLIA研究)

2016-10-24

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

JAMA：肺气肿的治疗：支气管内线圈治疗 vs 标准治疗（RENEW）

2017-03-09

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

Diabetes Care：糖尿病标准治疗时，低血糖可影响动脉粥样硬化进展

2016-08-18

小小小向日葵 (审核中...)

前往app查看评论内容

#标准治疗#

NEJM：低温联合标准治疗并不能更好的改善颅脑创伤患者的脑功能

2016-10-27

科室
- - 订阅+
  - 更多科室
工具
服务